Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
How it works: JAK2/growth hormone receptor upregulation: BPC-157 increases growth hormone receptor expression in tendon fibroblasts, sensitizing tissue to healing signals and accelerating structural repair FAK-paxillin pathway activation: enhances fibroblast migration and collagen deposition through focal adhesion kinase signaling, directly supporting connective tissue regeneration eNOS-driven angiogenesis: upregulates endothelial nitric oxide synthase to promote new blood vessel formation, improving oxygen and nutrient delivery to hypovascular tissues like tendons and ligaments Anti-inflammatory modulation: suppresses pro-inflammatory cytokines while preserving the early inflammatory phase needed for tissue repair, reducing chronic inflammation without blunting healing Administration: Subcutaneous injection (most common)
That process takes weeks to months, not days
Most drug targets are nucleophilic proteins, allowing them to act as excellent nucleophiles with electrophilic active groups
Mucus layers in inflammatory bowel disease
